UA6823U - Method for treating acute experimental pancreatitis - Google Patents

Method for treating acute experimental pancreatitis

Info

Publication number
UA6823U
UA6823U UA20041209835U UA20041209835U UA6823U UA 6823 U UA6823 U UA 6823U UA 20041209835 U UA20041209835 U UA 20041209835U UA 20041209835 U UA20041209835 U UA 20041209835U UA 6823 U UA6823 U UA 6823U
Authority
UA
Ukraine
Prior art keywords
treating acute
acute experimental
experimental pancreatitis
pancreatitis
treating
Prior art date
Application number
UA20041209835U
Inventor
Serhii Mykhailovych Demydov
Volodymyr Mykhailovych Demydov
Anatolii Mykhailovy Torbynskyi
Original Assignee
Univ Odesa State Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Odesa State Medical filed Critical Univ Odesa State Medical
Priority to UA20041209835U priority Critical patent/UA6823U/en
Publication of UA6823U publication Critical patent/UA6823U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The method for treating the acute experimental pancreatitis provides for intravenous administration of the liposomal form of Dalargin and intrabursal administration of Deltaran.
UA20041209835U 2004-12-01 2004-12-01 Method for treating acute experimental pancreatitis UA6823U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA20041209835U UA6823U (en) 2004-12-01 2004-12-01 Method for treating acute experimental pancreatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA20041209835U UA6823U (en) 2004-12-01 2004-12-01 Method for treating acute experimental pancreatitis

Publications (1)

Publication Number Publication Date
UA6823U true UA6823U (en) 2005-05-16

Family

ID=34883911

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20041209835U UA6823U (en) 2004-12-01 2004-12-01 Method for treating acute experimental pancreatitis

Country Status (1)

Country Link
UA (1) UA6823U (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008091177A1 (en) 2007-01-18 2008-07-31 Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes
EP3556377A1 (en) 2018-04-18 2019-10-23 PVP Labs PTE. Ltd. Antiviral immunotropic agent for the treatment of acute respiratory viral infections
EP3622964A1 (en) 2018-09-12 2020-03-18 PVP Labs PTE. Ltd. Agent for the treatment of skin wounds or burns

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008091177A1 (en) 2007-01-18 2008-07-31 Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes
EP3556377A1 (en) 2018-04-18 2019-10-23 PVP Labs PTE. Ltd. Antiviral immunotropic agent for the treatment of acute respiratory viral infections
EP3622964A1 (en) 2018-09-12 2020-03-18 PVP Labs PTE. Ltd. Agent for the treatment of skin wounds or burns

Similar Documents

Publication Publication Date Title
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
MX349188B (en) Sns-595 and methods of using the same.
PL377443A1 (en) Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
ZA200407813B (en) Medicament for preventing and/or treating chronic rejection.
WO2005048942A3 (en) Combination therapy comprising a cox-2 inhibitor and an antineoplastic agent
WO2006060507A3 (en) Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders
AU2002236527A1 (en) Nutrient supplements and methods for treating autism and for preventing the onset of autism
WO2005000213A3 (en) Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors
WO2006055871A3 (en) Treatment for multiple sclerosis
WO2005044093A3 (en) Delta-9- the treatment of multiple sclerosis
PL359056A1 (en) Compound emulsion, method of manufacture of the compound emulsion and application of the compound emulsion
NZ571858A (en) Methods of treating, reducing and inhibiting the appearance of ageing in the skin
EP1642592A4 (en) Remedy for sarcoidosis and method of treating the same
WO2008034116A3 (en) Products and methods using soy peptides to lower total and ldl cholesterol levels
TW200507840A (en) Method of treating multiple myeloma
WO2002094189A3 (en) Compositions and methods for treating or preventing convulsions or seizures
PT1596868E (en) Method for treating severe heart failure and medicament therefor
UA88655C2 (en) S-mirtazapine for the treatment of hot flush
WO2001052855A3 (en) Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
MY122838A (en) Treating allergic and inflammatory conditions
UA6823U (en) Method for treating acute experimental pancreatitis
AU2003252527A1 (en) Fatty emulsion injection of seal oil, method for preparation and the use in manufacturing intravenous injection
TW200637604A (en) Cosmetic compositions containing sophora alopecuroides L. extracts
WO2004080477A8 (en) Aplidine for multiple myeloma treatment